Results 11 to 20 of about 34,399 (185)

Eplerenone in the Treatment of Polypoidal Choroidal Vasculopathy

open access: yesCase Reports in Ophthalmology, 2015
Overactivation of mineralocorticoid receptor pathways has been implicated in the pathophysiology of central serous chorioretinopathy (CSCR). Recently, mineralocorticoid receptor antagonists such as eplerenone have demonstrated success in treating ...
Kapil G. Kapoor, Alan L. Wagner
doaj   +2 more sources

Polypoidal Choroidal Vasculopathy [PDF]

open access: yesCurrent Ophthalmology Reports, 2019
The aim of this review is to summarize developments in the treatment of active polypoidal choroidal vasculopathy (PCV). PCV is associated with a poor visual prognosis as a consequence the condition's hallmark polypoidal dilatation and a branching network resulting in recurrent hemorrhages and serous leakage.Recent research has provided new insights ...
Raquel, Goldhardt, Bradley Simon, Rosen
openaire   +3 more sources

Evolution of Polypoidal Lesions after Treatment of Polypoidal Choroidal Vasculopathy

open access: yesOphthalmology Science, 2022
Purpose: To evaluate the status and evolution of polypoidal lesions during the course of treatment of patients with symptomatic macular polypoidal choroidal vasculopathy (PCV).
Philippe Margaron   +2 more
exaly   +3 more sources

Pattern of presentation of idiopathic polypoidal choroidal vasculopathy in Ibadan, Sub-Saharan Africa

open access: yesClinical Ophthalmology, 2013
TS Oluleye, Y Babalola Retina and Vitreous Unit, Department of Ophthalmology, University of Ibadan and University College Hospital, Ibadan, Nigeria Background: Idiopathic polypoidal choroidal vasculopathy is an abnormal choroidal vascular pathology ...
Oluleye TS, Babalola Y
doaj   +1 more source

Pathologic study of early manifestations of polypoidal choroidal vasculopathy and pathogenesis of choroidal neo-vascularization

open access: yesAmerican Journal of Ophthalmology Case Reports, 2018
Purpose: To describe the histopathologic features of an early case of presumably bilateral polypoidal choroidal vasculopathy (PCV) in two eyes obtained at autopsy from a patient with no prior ocular therapy.
Mark O.M. Tso   +2 more
doaj   +2 more sources

Polypoidal choroidal vasculopathy in Caucasians

open access: yesGraefe's Archive for Clinical and Experimental Ophthalmology, 2000
To study the prevalence of polypoidal choroidal vasculopathy (PCV) in Caucasian patients with occult choroidal neovascularization (CNV); to study the clinical spectrum of PCV in Caucasians and the outcome after laser photocoagulation of such lesions.(1) A consecutive series of 374 eyes of Caucasian patients at least 58 years old, presenting occult CNV,
Lafaut, Bart   +4 more
openaire   +4 more sources

Choroidal excavation with polypoidal choroidal vasculopathy: a case report

open access: yesClinical Ophthalmology, 2012
Wataru Kobayashi,1 Toshiaki Abe,2 Hiroshi Tamai,1 Toru Nakazawa11Department of Ophthalmology, 2Division of Clinical Cell Therapy, Center for Advanced Medical Research and Development (ART), Tohoku University Graduate School of Medical Science, Sendai ...
Kobayashi W, Abe T, Tamai H, Nakazawa T
doaj   +1 more source

Photodynamic therapy for polypoidal choroidal vasculopathy secondary to choroidal nevus

open access: yesInternational Medical Case Reports Journal, 2017
James G Wong,1–3 Xin Jie Lai,1 Richard Y Sarafian,4 Hon Seng Wong,5 Jeremy B Smith6 1Strathfield Retina Clinic, Sydney, NSW, Australia; 2Medical Retina Unit, Sydney Eye Hospital, Sydney, NSW, Australia; 3Save Sight Institute, University of Sydney ...
Wong JG   +4 more
doaj   +3 more sources

Photodynamic therapy for polypoidal choroidal vasculopathy [PDF]

open access: yesProgress in Retinal and Eye Research, 2013
The first effective therapy for exudative macular degeneration (AMD) was Photodynamic Therapy (PDT). Diagnosis of the disease was to a large extent by fluorescein angiography (FA).
Patrycja Nowak-Sliwinska   +1 more
exaly   +2 more sources

Intravitreal aflibercept for polypoidal choroidal vasculopathy after developing ranibizumab tachyphylaxis

open access: yesClinical Ophthalmology, 2013
Masahiro Miura,1,2 Takuya Iwasaki,1,2 Hiroshi Goto2 1Department of Ophthalmology, Tokyo Medical University, Ibaraki Medical Center, Ami, Ibaraki, Japan; 2Department of Ophthalmology, Tokyo Medical University, Nishi-Shinjuku, Tokyo, Japan Purpose: To ...
Miura M, Iwasaki T, Goto H
doaj   +1 more source

Home - About - Disclaimer - Privacy